Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Revenue minus cost of goods sold

Percentile
P17
Within normal range
vs 5Y Ago
-7x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-23.90M-275.7%
2024$13.60M+955.2%
2023$1.29M+115.0%
2022$-8.59M-185.9%
2021$10.00M+193.0%
2020$3.41M+107.7%
2019$-44.10M-